Search Results 431-440 of 17360 for alopecia
Patient must be able to have recovered from all toxicities associated with chemoradiotherapy for anal cancer, to Grade ≤ 1 with the exception of alopecia.
About this study. The purpose of this study is to evaluate patterns of and changes in secretion levels of the stress hormone, cortisol and other steroid ...
Note: Stable chronic conditions (≤ Grade 2) that are not expected to resolve (such as neuropathy, myalgia, alopecia, prior therapy-related endocrinopathies) ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
... . VID-20147956. Home; Brightcove-Florida PRC director explains program. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be ...
Participants with ongoing >grade 1 toxicities from prior therapy (alopecia any grade and/or grade 2 neuropathy are permitted). - Participants with ...
alopecia, neuropathy, and specific laboratory abnormalities). 29. Administration of a live vaccine within 28 days before first dose of study drug. 30 ...
Toxicities due to prior therapy must be stable and recovered to ≤ Grade 1 (except for clinically non-significant toxicities, such as alopecia). Age 18 ...
Lichen sclerosus, Lichen planus, Skin wrinkles, Vulvar disorder, Acne, Alopecia areata, Melasma, Age spots, UV skin damage, Rosacea, Canker sores, Actinic ...
Unresolved toxicity (> Grade 1 or baseline) from previous anticancer or TGCT therapy, excluding alopecia. Known active CNS metastases. History or presence ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.